Rivanna Medical LLC – Trademark Portfolio

Entity Type: 16

Rivanna Medical LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include ACCURO, RIVANNA, and BONEENHANCE. The owner is based in Charlottesville, VA.

107 E Water Street

Charlottesville, VA 22902

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Rivanna Medical LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Rivanna Medical LLC have?

Rivanna Medical LLC has 8 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned.

What trademark classes does Rivanna Medical LLC file in?

Rivanna Medical LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Rivanna Medical LLC's most well-known trademarks?

Rivanna Medical LLC's registered trademark portfolio includes well-known marks such as ACCURO, RIVANNA, and BONEENHANCE. These are among 5 currently registered trademarks in the portfolio.

What is Rivanna Medical LLC's trademark registration success rate?

Rivanna Medical LLC has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.